Perspective Therapeutics, Inc. (CATX) Misses Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts CATX Hot Sheet
Join SI Premium – FREE
Perspective Therapeutics, Inc. (NYSE: CATX) reported Q2 EPS of ($0.18), $0.16 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $530 thousand versus the consensus estimate of $87.75 thousand.
For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- AI/ML Innovations plans $2M private placement on the CSE
- Perspective Therapeutics Inc (CATX) PT Lowered to $14 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
